Hong Xiao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Health Information

Cardiac Surgery

Top Venues

Future oncology (London, England)

Journal of clinical medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
María Díez-Campelo, Aylin Yucel, Ravi K Goyal, Rohan C Parikh, Elizabeth Esterberg, Maria Jimenez, Martina Sluga-O'Callaghan, Dimana Miteva, Hong Xiao, Ulrich Germing
Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe. Future oncology (London, England) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Ralph Boccia, Hong Xiao, Caroline von Wilamowitz-Moellendorff, Renuka Nardodkar, Sohan Deshpande, Sven L Klijn, Aylin Yucel
A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes. Journal of clinical medicine 13 (9) (2024)
Ralph Boccia, Hong Xiao, Caroline von Wilamowitz-Moellendorff, Renuka Nardodkar, Sohan Deshpande, Sven L Klijn, Aylin Yucel
A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes. Journal of clinical medicine 13 (9) (2024)
Markus Möhler, Hong Xiao, Steven I Blum, Elena Elimova, David Cella, Kohei Shitara, Jaffer A Ajani, Yelena Y Janjigian, Marcelo Garrido, Lin Shen, Kensei Yamaguchi, Tianshu Liu, Michael Schenker, Ruben Kowalyszyn, Arinilda Campos Bragagnoli, Ricardo Bruges, Vincenzo Montesarchio, Roberto A Pazo-Cid, Shannon Hunter, Eric Davenport, Jinyi Wang, Kaoru Kondo, Mingshun Li, Lucjan Wyrwicz
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hong Xiao, David Bertwistle, Keerun Khela, Chloe Middleton-Dalby, Jennifer Hall
Patient and caregiver socioeconomic burden of first-line systemic therapy for advanced gastroesophageal adenocarcinoma. Future oncology (London, England) 18 (10) (2022)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Chris Delcher, Hong Xiao, Cindy M Kortepeter, Almut G Winterstein
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility. Drug safety 43 (4) (2021)